Search research articles
Contact Us
Filters
Showing results (131-140 of 143) with videos related to
Page
of 15
Sort By:
ESMO Gastrointestinal Oncology
|
April 17, 2026
BevRam-GC01 study protocol: a phase I trial of bevacizumab plus ramucirumab and paclitaxel in advanced gastric cancer
T Wakatsuki, T Mashima, N Miyazaki, et al.
The Pharmacogenomics Journal
|
December 24, 2014
Distinct gene expression profiles of proximal and distal colorectal cancer: implications for cytotoxic and targeted therapy
M K H Maus, D L Hanna, C L Stephens, et al.
The Pharmacogenomics Journal
|
December 10, 2014
Integrin genetic variants and stage-specific tumor recurrence in patients with stage II and III colon cancer
P Bohanes, D Yang, F Loupakis, et al.
The Pharmacogenomics Journal
|
July 30, 2014
Genes involved in pericyte-driven tumor maturation predict treatment benefit of first-line FOLFIRI plus bevacizumab in patients with metastatic colorectal cancer
N B Volz, S Stintzing, W Zhang, et al.
ESMO Gastrointestinal Oncology
|
April 17, 2026
Semiquantitative CLDN18 expression and clinical outcomes in patients with CLDN18-positive gastric cancer treated with zolbetuximab plus chemotherapy
A Ooki, K Nakano, K Shimozaki, et al.
The Review of Scientific Instruments
|
November 29, 2014
Local current density measurement using a Rogowski probe in Tokyo Spherical Tokamak-2
H Furui, Y Nagashima, Y Takase, et al.
The Pharmacogenomics Journal
|
October 8, 2014
Genetic variants of kinase suppressors of Ras (KSR1) to predict survival in patients with ERα-positive advanced breast cancer
L Benhaim, W Zhang, T Wakatsuki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 21, 2014
Association of variants in genes encoding for macrophage-related functions with clinical outcome in patients with locoregional gastric cancer
Y Sunakawa, S Stremitzer, S Cao, et al.
The Pharmacogenomics Journal
|
October 28, 2015
Estrogen receptor-beta genetic variations and overall survival in patients with locally advanced gastric cancer
Y Sunakawa, S Cao, M D Berger, et al.
The Pharmacogenomics Journal
|
February 12, 2014
Prospective study of EGFR intron 1 (CA)n repeats variants as predictors of benefit from cetuximab and irinotecan in chemo-refractory metastatic colorectal cancer (mCRC) patients
F Loupakis, C Antoniotti, C Cremolini, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 143) with videos related to
Sort By:
Page
of 15
ESMO Gastrointestinal Oncology
|
April 17, 2026
BevRam-GC01 study protocol: a phase I trial of bevacizumab plus ramucirumab and paclitaxel in advanced gastric cancer
T Wakatsuki, T Mashima, N Miyazaki, et al.
The Pharmacogenomics Journal
|
December 24, 2014
Distinct gene expression profiles of proximal and distal colorectal cancer: implications for cytotoxic and targeted therapy
M K H Maus, D L Hanna, C L Stephens, et al.
The Pharmacogenomics Journal
|
December 10, 2014
Integrin genetic variants and stage-specific tumor recurrence in patients with stage II and III colon cancer
P Bohanes, D Yang, F Loupakis, et al.
The Pharmacogenomics Journal
|
July 30, 2014
Genes involved in pericyte-driven tumor maturation predict treatment benefit of first-line FOLFIRI plus bevacizumab in patients with metastatic colorectal cancer
N B Volz, S Stintzing, W Zhang, et al.
ESMO Gastrointestinal Oncology
|
April 17, 2026
Semiquantitative CLDN18 expression and clinical outcomes in patients with CLDN18-positive gastric cancer treated with zolbetuximab plus chemotherapy
A Ooki, K Nakano, K Shimozaki, et al.
The Review of Scientific Instruments
|
November 29, 2014
Local current density measurement using a Rogowski probe in Tokyo Spherical Tokamak-2
H Furui, Y Nagashima, Y Takase, et al.
The Pharmacogenomics Journal
|
October 8, 2014
Genetic variants of kinase suppressors of Ras (KSR1) to predict survival in patients with ERα-positive advanced breast cancer
L Benhaim, W Zhang, T Wakatsuki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 21, 2014
Association of variants in genes encoding for macrophage-related functions with clinical outcome in patients with locoregional gastric cancer
Y Sunakawa, S Stremitzer, S Cao, et al.
The Pharmacogenomics Journal
|
October 28, 2015
Estrogen receptor-beta genetic variations and overall survival in patients with locally advanced gastric cancer
Y Sunakawa, S Cao, M D Berger, et al.
The Pharmacogenomics Journal
|
February 12, 2014
Prospective study of EGFR intron 1 (CA)n repeats variants as predictors of benefit from cetuximab and irinotecan in chemo-refractory metastatic colorectal cancer (mCRC) patients
F Loupakis, C Antoniotti, C Cremolini, et al.
Page
of 15